Obagi Medical Products Condition & Enhance System National Consumer Awareness Campaign
Tweet
Obagi Medical Products, Inc., a leader in topical aesthetic and therapeutic skin health systems, today announced that it has launched its first-ever national consumer awareness campaign for the Obagi® Condition & Enhance System. The campaign was developed to educate consumers about the benefits of the skin care system, which was designed specifically to complement facial procedures and optimize overall aesthetic results. In addition, the campaign highlights the importance of partnering with a skincare professional to create an optimal treatment plan.
“We recognize the importance of consumer awareness and education in helping patients achieve their desired overall facial aesthetic results,” said Steve Carlson, Chief Executive Officer of Obagi Medical Products. “This is an important step in further partnering with our physicians to share the excitement and success of current Obagi users with millions of other consumers looking for a results-driven approach to aesthetic management.”
The campaign will feature print advertisements in national magazines, including Allure and O, The Oprah Magazine, as well as online banner ads on select Web sites, such as Yahoo! and iVillage. The campaign goal is to reach approximately 26 million aesthetically aware women, between the ages of 25 and 55.
As a part of the new awareness campaign, Obagi Medical Products is launching a new Condition & Enhance Web site that encourages consumers to partner with a physician or skincare specialist to improve the overall health of their skin. In addition, the Web site contains valuable information on the Obagi Condition & Enhance System, and includes the following interactive features:
* A Physician Locator which enables consumers to find a skin care professional in their area, who carries the Obagi Medical Products lines;
* “Face File,” a unique tool that allows consumers to create and personalize a profile that stores procedures they have already received or are interested in, and provides a checklist of topics to discuss with their physician or skincare specialist;
* “Refill Reminders” that allow consumers to sign up for an e-mail or phone text notification when it is time to re-fill the products in their Obagi Condition & Enhance System;
* Information on common non-surgical procedures and how the Obagi Condition & Enhance System works to complement them.
The Web site, www.ConditionAndEnhance.com, was launched at last week’s American Academy of Dermatology Summer Meeting in Chicago.
“At Obagi, we strive to empower patients to take charge of their skin care by partnering with their physician or skincare specialist,” said Rick Kozloski, Vice President of Marketing and Dermatology at Obagi Medical Products. “The Obagi Condition & Enhance System is a great complement for any facial procedure, and this campaign will further educate consumers seeking to improve their overall aesthetic appearance and learn about the many benefits of this system.”
For more information, visit www.ConditionAndEnhance.com or www.obagi.com.
About the Condition & Enhance System
The 4% hydroquinone-based skin care program, known commercially as the Obagi® Condition & Enhance System, helps correct premature photoaged skin and prevent future skin damage. The system is comprised of products that work together to improve overall skin health and appearance. The Condition & Enhance System, which utilizes Obagi’s Penetrating Therapeutics™, includes cleanser, toner, 4% hydroquinone, exfoliant, and sunscreen SPF 35 for complete skin care.
The order and frequency of application of products in the Condition & Enhance System are carefully defined and managed by the physician to create a four-step process for improving and restoring overall skin quality. The first step is skin preparation, the second step is skin correction, the third step is skin stimulation, and the fourth step is skin protection.
See Also:
If you enjoyed this post, please consider leaving a comment, subscribe to the feed and get future articles delivered to your feed reader or follow us on Twitter.
Comments
No comments yet.
Leave a comment